CClinicalTrials.gg
CompletedNCT04075591Updated Jul 23, 2026Results posted

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

An interventional study of iDesign Refractive Studio with STAR S4 IR® Excimer laser System in Refractive Error, sponsored by AMO Development, LLC. Completed at 10 sites in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-07-23.

Sponsored by AMO Development, LLC · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
219
Allocation
Not applicable
Ages
40 Years and older
Sex
All
01

Study summary

This study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 sites. A total of 383 subjects will be enrolled to achieve approximately 268 treated subjects, resulting in at least 241 evaluable subjects at the point of refractive stability. After signing the informed consent, subjects meeting all inclusion and exclusion criteria in both eyes may be scheduled for surgery. The follow-up visit schedule will be the same for each operative eye.

02

Conditions studied

  • Refractive Error

Browse trials for

03

In context

Refractive Errors

413 studies on the registry are indexed under Refractive Errors; 62 are open to participants now.

This study's enrollment of 219 is above the median of 82 across 296 interventional studies indexed under Refractive Errors.

Browse Refractive Errors studies →

Lead sponsor

This is the only study on the registry with AMO Development, LLC as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Signed informed consent and HIPAA authorization.
  2. At least 40 years of age at enrollment (date informed consent signed).
  3. The refractive error of both subject's eyes, based on the iDesign refraction selected for treatment ("4.0 mm Rx calc" at 12.5 mm), must be myopic with or without astigmatism up to -6.00 D spherical equivalent (SE), with cylinder up to -3.00 D and minimum pre-operative myopia in their non-dominant eye at least as great as their targeted myopic retention.
  4. At least one eye must require a myopic treatment.
  5. Anticipated stromal bed thickness of at least 250 microns based on preoperative central corneal pachymetry minus the maximum treatment depth to be ablated (as calculated by the iDesign plus the intended flap thickness).
  6. Distance Best Spectacle Corrected Visual Acuity (BSCVA) of 20/20 or better.
  7. Require an add power of +1.25 D or more but not greater than +2.00 D at 40 cm.
  8. Less than or equal to ±0.50 D difference between cycloplegic and manifest refraction sphere.
  9. A stable refractive error (based on a previous exam, medical records, lensometry, or prescription that is at least 12 months prior to the preoperative manifest refraction), as defined by a change of less than or equal to

    • 0.50 D in MRSE (sphere and cylinder).
  10. Subjects with a history of contact lens wear within the last 4 weeks must discontinue lens wear in order to demonstrate refractive stability according to the following (refractive stability is defined as a change of not more than 0.50 D in manifest refraction sphere and cylinder as well as mean keratometry between measurements): After the Informed Consent process has been completed and subjects are enrolled in the study:

    • Rigid or extended wear contact lenses (toric or spherical) must be removed for at least 3 weeks and soft contact lenses (toric or spherical) for at least 2 weeks prior to the first refraction used to establish stability.
    • After abstaining from contact lens wear for designated time, two consecutive manifest refractions and keratometric readings must be conducted at least 7 days apart
    • I If the subject/eye meets the refractive stability criteria, contact lens wear is not permitted for 2 weeks prior to surgery except as required to test monovision acceptance as described below in the Study Procedures, Contact Lens Trial section NOTE: Refractive stability needs to be confirmed only once during preoperative assessment
  11. Agreement between manifest refraction (adjusted for optical infinity) and iDesign System refraction chosen for treatment, as follows:

    • Spherical Equivalent: magnitude of the difference is less than 0.625 D.
    • Cylinder: magnitude of the difference is less than or equal to 0.5 D.
    • Cylinder Axis Tolerance: If either the manifest cylinder entered into the iDesign System or the iDesign cylinder selected for treatment is less than 0.5 D, there is no requirement for axis agreement. When both cylinders have a magnitude of at least 0.5 D, the axis tolerance as determined by the iDesign system is linearly reduced from 15 degrees (0.5 D) to 7.5 degrees (7.0 D) based on the average magnitude of both cylinders. Note: If the axis tolerance is not in the calculated range, the iDesign system will produce a warning and this exam may not be used for treatment planning.
  12. Willing and capable of complying with follow-up examinations for the duration of the study.

Exclusion criteria

Exclusion Criteria:

  1. Women who are pregnant, breast-feeding, or intend to become pregnant during the study.

    Note: Women who were pregnant or nursing may not be enrolled until 6 months after either delivery or have stopped nursing and there is documented refractive stability.

  2. Concurrent use of systemic (including inhaled) medications that may impair healing, including but not limited to: antimetabolites, isotretinoin (Accutane®) within 6 months of treatment, and amiodarone hydrochloride (Cordarone®) within 12 months of treatment. NOTE: The use of inhaled or systemic corticosteroids, whether chronic or acute, within the past 6 months is deemed to adversely affect healing and subjects using such medications are specifically excluded from eligibility.
  3. History of any of the following medical conditions, or any other condition that could affect wound healing: collagen vascular disease, autoimmune disease, immunodeficiency diseases, ocular herpes zoster or herpes simplex, endocrine disorders (including, but not limited to unstable thyroid disorders and diabetes), lupus, and rheumatoid arthritis.

    NOTE: The presence of diabetes (either type 1 or 2), regardless of disease duration, severity, or control, will specifically exclude subjects from eligibility.

  4. Subjects with a cardiac pacemaker, implanted defibrillator or other implanted electronic device.
  5. History of prior intraocular or corneal surgery (including cataract extraction), active ophthalmic disease or abnormality (including, but not limited to, symptomatic blepharitis, recurrent corneal erosion, dry eye syndrome, neovascularization > 1 mm from limbus), retinal detachment/repair, clinically significant lens opacity, clinical evidence of trauma, corneal opacity within the central 9 mm and visible on topography, prior strabismus surgery, strabismus, or at risk for developing strabismus, or with evidence of glaucoma or propensity for narrow angle glaucoma or suspected glaucoma.

    NOTE: Subjects with glaucoma, regardless of medication regimen or control, or an IOP greater than 21 mmHg at screening, are specifically excluded from eligibility.

  6. Evidence of keratoconus, corneal dystrophy or irregularity, or abnormal topography.
  7. Known sensitivity or inappropriate responsiveness to any of the medications used in the postoperative course.
  8. Intolerance to monovision correction based on questionnaire responses to contact lens trial (refer to section Study Procedures, Contact Lens Trial below).
  9. Concurrent participation in any other clinical trial, or participation in any other clinical trial within the last 14 days.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
219 participants (actual)

Study arms

  • Experimental
    Wavefront-guided Lasik Monovision Treatment

    Wavefront-guided LASIK monovision treatment of myopic subjects with presbyopia using the STAR S4 IR® Excimer laser System with the iDesign Refractive Studio.

    Device: iDesign Refractive Studio with STAR S4 IR® Excimer laser System

Interventions

  • DeviceiDesign Refractive Studio with STAR S4 IR® Excimer laser System

    Surgeons will perform wavefront-guided monovision LASIK for the treatment of myopic subjects with presbyopia based upon measurements obtained with an iDesign Refractive Studio.

06

What researchers measure

Primary outcomes

  1. Change in Driving Scale Score From Preoperative to Postoperative as Measured by Driving Scale Within Patient-Reported Outcomes With LASIK for Monovision (PROWL-M)

    Change in driving scale score from preoperative to postoperative as measured by driving scale within PROWL-M was reported. PROWL-M driving scale consists of three driving related items that were used to generate the driving scale score. Each item response was converted to a 0 to 100 scale so that the lowest and highest possible scores were set at 0 (not functioning) and 100 (functioning) points. A high score represents better functioning. The composite driving scale score was calculated by averaging the scores of all the three items, resulting in a total score ranging from 0 to 100 where higher score represent better functioning. Change in driving scale score was defined as the driving scale score at 12-month visit minus the driving scale score at preoperative visit.

    Time frame: From preoperative (within 120 to 14 days prior to surgery on Day 0) to 12 month postoperative (operated on Day 0)

  2. Percentage of Participants Who Required Secondary Surgery to Reverse Monovision

    Percentage of participants who required secondary surgery to reverse monovision was reported.

    Time frame: At 12 month postoperative (operated on Day 0)

Secondary outcomes

  1. Percentage of Participants Who Experienced Bothersome Visual Symptom (Double Image) as Assessed by PROWL-M: In Last 7 Days, How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?

    Percentage of participants who experienced bothersome visual symptom (double image) as assessed by PROWL-M (in Last 7 Days, how bothersome have the symptoms been when wearing the best vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In last 7 days how bothersome have the double images symptoms been when wearing the best vision correction" of double images was categorize as: (1) participant do not use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

    Time frame: 3 months, 6 months, 12 months postoperative (operated on Day 0)

  2. Percentage of Participants Who Experienced Bothersome Visual Symptom (Double Image) as Assessed by PROWL-M: In Last 7 Days, How Bothersome Have the Symptoms Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?

    Percentage of participants who experienced bothersome visual symptom (double image) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when not wearing any vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the double images been symptoms been when not wearing any vision correction (glasses or contact lenses)" was categorize as: (1) participant always use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

    Time frame: 3 months, 6 months, 12 months postoperative (operated on Day 0)

  3. Percentage of Participants Who Experienced Bothersome Visual Symptom (Glare) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?

    Percentage of participants who experienced bothersome visual symptom (glare) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when wearing the best vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the glare been when wearing the best vision correction (glasses or contact lenses)" was categorize as: (1) participant do not use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

    Time frame: 3 months, 6 months, 12 months postoperative (operated on Day 0)

  4. Percentage of Participants Who Experienced Bothersome Visual Symptom (Glare) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?

    Percentage of participants who experienced bothersome visual symptom (glare) as assessed by PROWL-M questionnaire was reported. The PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when not wearing any vision correction \[glasses or contact lenses\]) was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the glare been when not wearing any vision correction (glasses or contact lenses)" was categorize as: (1) participant always use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

    Time frame: 3 months, 6 months, 12 months postoperative (operated on Day 0)

  5. Percentage of Participants Who Experienced Bothersome Visual Symptom (Halo) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?

    Percentage of participants who experienced bothersome visual symptom (halo) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when wearing the best vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the Halos been when wearing the best vision correction (glasses or contact lenses)" was categorize as: (1) participant do not use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

    Time frame: 3 months, 6 months, 12 months postoperative (operated on Day 0)

  6. Percentage of Participants Who Experienced Bothersome Visual Symptom (Halo) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?

    Percentage of participants who experienced bothersome visual symptom (halo) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when not wearing any vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the halos been when not wearing any vision correction (glasses or contact lenses)" was categorize as: (1) participant always use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

    Time frame: 3 months, 6 months, and 12 months postoperative (operated on Day 0)

  7. Percentage of Participants Who Experienced Bothersome Visual Symptom (Starbursts) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?

    Percentage of participants who experienced bothersome visual symptom (starbursts) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when wearing the best vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the starbursts been when wearing the best vision correction (glasses or contact lenses)" was categorize as: (1) participant do not use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

    Time frame: 3 months, 6 months, and 12 months postoperative (operated on Day 0)

  8. Percentage of Participants Who Experienced Bothersome Visual Symptom (Starbursts) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptom Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?

    Percentage of participants who experienced bothersome visual symptom (starbursts) as assessed by PROWL-M questionnaire (in Last 7 Days, how bothersome have the symptoms been when not wearing any vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the starbursts been when not wearing any vision correction (glasses or contact lenses)" was categorize as: (1) participant always use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

    Time frame: 3 months, 6 months, and 12 months postoperative (operated on Day 0)

  9. Percentage of Participants Who Experienced Moderate to Severe Difficulty in Activities

    Percentage of participants who experienced moderate to severe difficulty in activities was reported. Participants were asked questions about the difficulty they faced with daily activities, work or hobbies, reading, and judging distances. Responses was collected in 6 categories: (1) No difficulty at all, (2) A little difficulty, (3) moderate difficulty, (4) a lot of difficulty, (5) never try to do these activities because of vision, (6) Never do these activities for other reasons. Categories with non-zero data values are reported.

    Time frame: Preoperative (within 120 to 14 days prior to surgery on Day 0), 3 months, 6 months, and 12 months postoperative (operated on Day 0)

  10. Percentage of Participants Who Experienced Satisfaction With Vision as Measured by PROWL-M Questionnaire

    Percentage of participants who experienced satisfaction with vision was reported. Satisfaction with vision was assessed using a single-item question in the PROWL-M questionnaire. Participants were asked a question "In general, how satisfied or dissatisfied are you with your present vision". Responses was collected in 6 categories: (1) completely satisfied, (2) very satisfied, (3) somewhat satisfied, (4) somewhat dissatisfied, (5) very dissatisfied, (6) completely dissatisfied. Categories with non-zero data values are reported.

    Time frame: Preoperative (within 120 to 14 days prior to surgery on Day 0), 3 months, 6 months, and 12 months postoperative (operated on Day 0)

  11. Subject Satisfaction Score With Surgery as Measured by PROWL-M Questionnaire

    A questionnaire derived from the PROWL-M was given to participants after surgery. Satisfaction with LASIK via PROWL-M questionnaire was assessed with 8 items. Responses to individual items were linearly transformed to a 0 to 100 scale where 100 indicates best possible vision and satisfaction, while 0 indicates worst possible vision and satisfaction. Each item score was averaged together to produce a score ranging from 0 to 100. A higher score indicating greater satisfaction.

    Time frame: 3 months, 6 months, and 12 months postoperative (operated on Day 0)

  12. Percentage of Participants Who Achieved 20/40 Or Better Simultaneous Binocular Uncorrected Visual Acuity (UCVA)

    Percentage of participants who achieved 20/40 or better simultaneous binocular UCVA measured using Good-Lite 100 percent (%) proportionally spaced SLOAN letter/ETDRS charts designed for 4.0 meter (m) and the Good-Lite self-illuminated and self-calibrated illumination box were reported.

    Time frame: Preoperative (within 120 to 14 days prior to surgery on Day 0), 3 months, 6 months, and 12 months postoperative (operated on Day 0)

07

Results

Posted Jul 23, 2026

Participant flow

Participant flow — Overall Study
MilestoneWavefront-guided LASIK Monovision Treatment
Started219
Safety analysis set159
Completed153
Not completed66
Withdrew: Enrolled but not treated60
Withdrew: Lost to follow-up1
Withdrew: Non-johnson & johnson device used3
Withdrew: Retreatment not done using idesign1
Withdrew: Participants requested surgical intervention for vision complaints1

Outcome measures

PrimaryChange in Driving Scale Score From Preoperative to Postoperative as Measured by Driving Scale Within Patient-Reported Outcomes With LASIK for Monovision (PROWL-M)

Change in driving scale score from preoperative to postoperative as measured by driving scale within PROWL-M was reported. PROWL-M driving scale consists of three driving related items that were used to generate the driving scale score. Each item response was converted to a 0 to 100 scale so that the lowest and highest possible scores were set at 0 (not functioning) and 100 (functioning) points. A high score represents better functioning. The composite driving scale score was calculated by averaging the scores of all the three items, resulting in a total score ranging from 0 to 100 where higher score represent better functioning. Change in driving scale score was defined as the driving scale score at 12-month visit minus the driving scale score at preoperative visit.

Time frame:
From preoperative (within 120 to 14 days prior to surgery on Day 0) to 12 month postoperative (operated on Day 0)
Reported as:
Mean · Score on a scale
Change in Driving Scale Score From Preoperative to Postoperative as Measured by Driving Scale Within Patient-Reported Outcomes With LASIK for Monovision (PROWL-M)
Score on a scaleWavefront-guided LASIK Monovision Treatment
Change in Driving Scale Score From Preoperative to Postoperative as Measured by Driving Scale Within Patient-Reported Outcomes With LASIK for Monovision (PROWL-M)1.8 ± 16.63
PrimaryPercentage of Participants Who Required Secondary Surgery to Reverse Monovision

Percentage of participants who required secondary surgery to reverse monovision was reported.

Time frame:
At 12 month postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Required Secondary Surgery to Reverse Monovision
Percentage of participantsWavefront-guided LASIK Monovision Treatment
Percentage of Participants Who Required Secondary Surgery to Reverse Monovision0
SecondaryPercentage of Participants Who Experienced Bothersome Visual Symptom (Double Image) as Assessed by PROWL-M: In Last 7 Days, How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?

Percentage of participants who experienced bothersome visual symptom (double image) as assessed by PROWL-M (in Last 7 Days, how bothersome have the symptoms been when wearing the best vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In last 7 days how bothersome have the double images symptoms been when wearing the best vision correction" of double images was categorize as: (1) participant do not use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

Time frame:
3 months, 6 months, 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Bothersome Visual Symptom (Double Image) as Assessed by PROWL-M: In Last 7 Days, How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?
Percentage of participantsWavefront-guided LASIK Monovision Treatment
3 months: participant do not use glasses or contact lenses0.6
3 months: Extremely bothersome0.6
3 months: Very bothersome0
3 months: Somewhat bothersome0
3 months: A little bothersome0.6
3 months: Not at all bothersome0
3 month: participants who did not experience symptom98.1
6 months: participant do not use glasses or contact lenses0.6
6 months: Extremely bothersome0.6
6 months: Very bothersome0.6
6 months: Somewhat bothersome0
6 months: A little bothersome0.6
6 months: Not at all bothersome0
6 month: participants who did not experience symptom97.5
12 months: participant do not use glasses or contact lenses0.6
12 months: Extremely bothersome0.6
12 months: Very bothersome0.6
12 months: Somewhat bothersome0
12 months: A little bothersome0.6
12 months: Not at all bothersome0.6
12 month: participants who did not experience symptom96.9
SecondaryPercentage of Participants Who Experienced Bothersome Visual Symptom (Double Image) as Assessed by PROWL-M: In Last 7 Days, How Bothersome Have the Symptoms Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?

Percentage of participants who experienced bothersome visual symptom (double image) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when not wearing any vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the double images been symptoms been when not wearing any vision correction (glasses or contact lenses)" was categorize as: (1) participant always use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

Time frame:
3 months, 6 months, 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Bothersome Visual Symptom (Double Image) as Assessed by PROWL-M: In Last 7 Days, How Bothersome Have the Symptoms Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?
Percentage of participantsWavefront-guided LASIK Monovision Treatment
3 months: participant always use glasses or contact lenses0.6
3 months: Extremely bothersome0.6
3 months: Very bothersome0
3 months: Somewhat bothersome1.3
3 months: A little bothersome7.6
3 months: Not at all bothersome0
3 month: participants who did not experience symptom89.8
6 months: participant always use glasses or contact lenses1.3
6 months: Extremely bothersome0.6
6 months: Very bothersome0.6
6 months: Somewhat bothersome2.5
6 months: A little bothersome7.5
6 months: Not at all bothersome0.6
6 month: participants who did not experience symptom86.8
12 months: participant always use glasses or contact lenses0.6
12 months: Extremely bothersome0.6
12 months: Very bothersome1.3
12 months: Somewhat bothersome4.4
12 months: A little bothersome6.9
12 months: Not at all bothersome1.3
12 month: participants who did not experience symptom84.9
SecondaryPercentage of Participants Who Experienced Bothersome Visual Symptom (Glare) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?

Percentage of participants who experienced bothersome visual symptom (glare) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when wearing the best vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the glare been when wearing the best vision correction (glasses or contact lenses)" was categorize as: (1) participant do not use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

Time frame:
3 months, 6 months, 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Bothersome Visual Symptom (Glare) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?
Percentage of participantsWavefront-guided LASIK Monovision Treatment
3 months: participant do not use glasses or contact lenses5.1
3 months: Extremely bothersome0
3 months: Very bothersome1.3
3 months: Somewhat bothersome1.3
3 months: A little bothersome1.3
3 months: Not at all bothersome0
3 month: participants who did not experience symptom91.1
6 months: participant do not use glasses or contact lenses9.4
6 months: Extremely bothersome0
6 months: Very bothersome1.3
6 months: Somewhat bothersome1.9
6 months: A little bothersome3.1
6 months: Not at all bothersome0
6 month: participants who did not experience symptom84.3
12 months: participant do not use glasses or contact lenses10.1
12 months: Extremely bothersome0
12 months: Very bothersome1.3
12 months: Somewhat bothersome1.9
12 months: A little bothersome4.4
12 months: Not at all bothersome0.6
12 month: participants who did not experience symptom81.8
SecondaryPercentage of Participants Who Experienced Bothersome Visual Symptom (Glare) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?

Percentage of participants who experienced bothersome visual symptom (glare) as assessed by PROWL-M questionnaire was reported. The PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when not wearing any vision correction \[glasses or contact lenses\]) was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the glare been when not wearing any vision correction (glasses or contact lenses)" was categorize as: (1) participant always use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

Time frame:
3 months, 6 months, 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Bothersome Visual Symptom (Glare) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?
Percentage of participantsWavefront-guided LASIK Monovision Treatment
3 months: participant always use glasses or contact lenses0.6
3 months: Extremely bothersome0
3 months: Very bothersome1.3
3 months: Somewhat bothersome3.8
3 months: A little bothersome10.2
3 months: Not at all bothersome4.5
3 month: participants who did not experience symptom79.6
6 months: participant always use glasses or contact lenses1.9
6 months: Extremely bothersome0
6 months: Very bothersome0.6
6 months: Somewhat bothersome6.9
6 months: A little bothersome15.1
6 months: Not at all bothersome5.0
6 month: participants who did not experience symptom70.4
12 months: participant always use glasses or contact lenses1.3
12 months: Extremely bothersome0
12 months: Very bothersome1.3
12 months: Somewhat bothersome3.8
12 months: A little bothersome20.8
12 months: Not at all bothersome6.3
12 month: participants who did not experience symptom66.7
SecondaryPercentage of Participants Who Experienced Bothersome Visual Symptom (Halo) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?

Percentage of participants who experienced bothersome visual symptom (halo) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when wearing the best vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the Halos been when wearing the best vision correction (glasses or contact lenses)" was categorize as: (1) participant do not use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

Time frame:
3 months, 6 months, 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Bothersome Visual Symptom (Halo) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?
Percentage of participantsWavefront-guided LASIK Monovision Treatment
3 months: participant do not use glasses or contact lenses3.2
3 months: Extremely bothersome0
3 months: Very bothersome0.6
3 months: Somewhat bothersome1.9
3 months: A little bothersome4.5
3 months: Not at all bothersome0.6
3 month: participants who did not experience symptom89.2
6 months: participant do not use glasses or contact lenses4.4
6 months: Extremely bothersome0
6 months: Very bothersome0.6
6 months: Somewhat bothersome2.5
6 months: A little bothersome6.3
6 months: Not at all bothersome1.3
6 month: participants who did not experience symptom84.9
12 months: participant do not use glasses or contact lenses8.2
12 months: Extremely bothersome0
12 months: Very bothersome0.6
12 months: Somewhat bothersome1.9
12 months: A little bothersome8.8
12 months: Not at all bothersome1.9
12 month: participants who did not experience symptom78.6
SecondaryPercentage of Participants Who Experienced Bothersome Visual Symptom (Halo) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?

Percentage of participants who experienced bothersome visual symptom (halo) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when not wearing any vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the halos been when not wearing any vision correction (glasses or contact lenses)" was categorize as: (1) participant always use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

Time frame:
3 months, 6 months, and 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Bothersome Visual Symptom (Halo) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?
Percentage of participantsWavefront-guided LASIK Monovision Treatment
3 months: participants always use glasses or contact lenses1.3
3 months: Extremely bothersome0
3 months: Very bothersome0
3 months: Somewhat bothersome7.0
3 months: A little bothersome18.5
3 months: Not at all bothersome8.9
3 months: participants who did not experience symptom64.3
6 months: participants always use glasses or contact lenses2.5
6 months: Extremely bothersome0
6 months: Very bothersome0
6 months: Somewhat bothersome9.4
6 months: A little bothersome20.1
6 months: Not at all bothersome13.8
6 months: participants who did not experience symptom54.1
12 months: participants always use glasses or contact lenses1.9
12 months: Extremely bothersome0
12 months: Very bothersome0
12 months: Somewhat bothersome6.9
12 months: A little bothersome25.8
12 months: Not at all bothersome15.7
12 months: participants who did not experience symptom49.7
SecondaryPercentage of Participants Who Experienced Bothersome Visual Symptom (Starbursts) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?

Percentage of participants who experienced bothersome visual symptom (starbursts) as assessed by PROWL-M questionnaire (in last 7 days, how bothersome have the symptoms been when wearing the best vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the starbursts been when wearing the best vision correction (glasses or contact lenses)" was categorize as: (1) participant do not use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

Time frame:
3 months, 6 months, and 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Bothersome Visual Symptom (Starbursts) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptoms Been When Wearing the Best Vision Correction (Glasses or Contact Lenses)?
Percentage of participantsWavefront-guided LASIK Monovision Treatment
3 months: participants do not use glasses or contact lenses2.5
3 months: Extremely bothersome0
3 months: Very bothersome0.6
3 months: Somewhat bothersome1.9
3 months: A little bothersome4.5
3 months: Not at all bothersome1.3
3 months: participants who did not experience symptom89.2
6 months: participants do not use glasses or contact lenses7.5
6 months: Extremely bothersome0
6 months: Very bothersome1.3
6 months: Somewhat bothersome2.5
6 months: A little bothersome6.3
6 months: Not at all bothersome1.9
6 months: participants who did not experience symptom80.5
12 months: participants do not use glasses or contact lenses8.8
12 months: Extremely bothersome0
12 months: Very bothersome0.6
12 months: Somewhat bothersome3.1
12 months: A little bothersome7.5
12 months: Not at all bothersome3.1
12 months: participants who did not experience symptom76.8
SecondaryPercentage of Participants Who Experienced Bothersome Visual Symptom (Starbursts) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptom Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?

Percentage of participants who experienced bothersome visual symptom (starbursts) as assessed by PROWL-M questionnaire (in Last 7 Days, how bothersome have the symptoms been when not wearing any vision correction \[glasses or contact lenses\]) was reported. The PROWL-M questionnaire was designed to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery. The response for question "In the last 7 days how bothersome have the starbursts been when not wearing any vision correction (glasses or contact lenses)" was categorize as: (1) participant always use glasses or contact lenses, (2) extremely bothersome, (3) very bothersome, (4) somewhat bothersome, (5) a little bothersome, (6) not at all bothersome.

Time frame:
3 months, 6 months, and 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Bothersome Visual Symptom (Starbursts) as Assessed by PROWL-M: In the Last 7 Days How Bothersome Have the Symptom Been When Not Wearing Any Vision Correction (Glasses or Contact Lenses)?
Percentage of participantsWavefront-guided LASIK Monovision Treatment
3 months: Participants always use glasses or contact lenses0
3 months: Extremely bothersome0.6
3 months: Very bothersome1.3
3 months: Somewhat bothersome8.3
3 months: A little bothersome19.1
3 months: Not at all bothersome14.6
3 months: participants who did not experience symptom56.1
6 months: Participants always use glasses or contact lenses1.3
6 months: Extremely bothersome0
6 months: Very bothersome0.6
6 months: Somewhat bothersome8.2
6 months: A little bothersome23.9
6 months: Not at all bothersome18.9
6 months: participants who did not experience symptom47.2
12 months: Participants always use glasses or contact lenses0.6
12 months: Extremely bothersome0
12 months: Very bothersome2.5
12 months: Somewhat bothersome5.0
12 months: A little bothersome32.1
12 months: Not at all bothersome22.0
12 months: participants who did not experience symptom37.7
SecondaryPercentage of Participants Who Experienced Moderate to Severe Difficulty in Activities

Percentage of participants who experienced moderate to severe difficulty in activities was reported. Participants were asked questions about the difficulty they faced with daily activities, work or hobbies, reading, and judging distances. Responses was collected in 6 categories: (1) No difficulty at all, (2) A little difficulty, (3) moderate difficulty, (4) a lot of difficulty, (5) never try to do these activities because of vision, (6) Never do these activities for other reasons. Categories with non-zero data values are reported.

Time frame:
Preoperative (within 120 to 14 days prior to surgery on Day 0), 3 months, 6 months, and 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Moderate to Severe Difficulty in Activities
Percentage of participantsWavefront-guided LASIK Monovision Treatment
Difficulty with daily activities: no difficulty at all: Preoperative71.1
Difficulty with daily activities: a little difficulty: Preoperative23.3
Difficulty with daily activities: moderate difficulty: Preoperative4.4
Difficulty with daily activities: a lot of difficulty: Preoperative1.3
Difficulty with daily activities: no difficulty at all: 3 months74.5
Difficulty with daily activities: a little difficulty: 3 months23.6
Difficulty with daily activities: moderate difficulty: 3 months1.9
Difficulty with daily activities: no difficulty at all: 6 months82.7
Difficulty with daily activities: a little difficulty: 6 months17.3
Difficulty with daily activities: no difficulty at all: 12 months85.0
Difficulty with daily activities: a little difficulty: 12 months15.0
Difficulty during work or hobbies: no difficulty at all: preoperative39.0
Difficulty during work or hobbies: a little difficulty: preoperative42.8
Difficulty during work or hobbies: moderate difficulty: preoperative13.8
Difficulty during work or hobbies: a lot of difficulty: preoperative4.4
Difficulty during work or hobbies: no difficulty at all: 3 months49.7
Difficulty during work or hobbies: a little difficulty: 3 months38.2
Difficulty during work or hobbies: moderate difficulty: 3 months8.9
Difficulty during work or hobbies: a lot of difficulty: 3 months3.2
Difficulty during work or hobbies: no difficulty at all: 6 months54.7
Difficulty during work or hobbies: a little difficulty: 6 months34.7
Difficulty during work or hobbies: moderate difficulty: 6 months8.0
Difficulty during work or hobbies: a lot of difficulty: 6 months2.7
Difficulty during work or hobbies: no difficulty at all: 12 months54.2
Difficulty during work or hobbies: a little difficulty: 12 months35.3
Difficulty during work or hobbies: moderate difficulty: 12 months8.5
Difficulty during work or hobbies: a lot of difficulty: 12 months2.0
Difficulty reading small print: no difficulty at all: Preoperative27.7
Difficulty reading small print: a little difficulty: Preoperative37.7
Difficulty reading small print: moderate difficulty: Preoperative21.4
Difficulty reading small print: a lot of difficulty: Preoperative12.6
Difficulty reading small print: never try to do this because of vision: Preoperative0.6
Difficulty reading small print: no difficulty at all: 3 months34.4
Difficulty reading small print: a little difficulty: 3 months40.1
Difficulty reading small print: moderate difficulty: 3 months17.2
Difficulty reading small print: a lot of difficulty: 3 months8.3
Difficulty reading small print: no difficulty at all: 6 months36.0
Difficulty reading small print: a little difficulty: 6 months39.3
Difficulty reading small print: moderate difficulty: 6 months16.0
Difficulty reading small print: a lot of difficulty: 6 months8.0
Difficulty reading small print: never try to do this because of vision: 6 months0.7
Difficulty reading small print: no difficulty at all: 12 months35.3
Difficulty reading small print: a little difficulty: 12 months45.8
Difficulty reading small print: moderate difficulty: 12 months12.4
Difficulty reading small print: a lot of difficulty: 12 months5.9
Difficulty reading small print: never try to do this because of vision: 12 months0.7
Difficulty judging distances: no difficulty at all: preoperative83.0
Difficulty judging distances: a little difficult: preoperative13.8
Difficulty judging distances: moderate difficult: preoperative2.5
Difficulty judging distances: a lot of difficult: preoperative0.6
Difficulty judging distances: no difficulty at all: 3 months90.4
Difficulty judging distances: a little difficulty: 3 months9.6
Difficulty judging distances: no difficulty at all: 6 months89.3
Difficulty judging distances: a little difficulty: 6 months9.3
Difficulty judging distances: moderate difficulty: 6 months1.3
Difficulty judging distances: no difficulty at all: 12 months88.2
Difficulty judging distances: a little difficulty: 12 months11.8
SecondaryPercentage of Participants Who Experienced Satisfaction With Vision as Measured by PROWL-M Questionnaire

Percentage of participants who experienced satisfaction with vision was reported. Satisfaction with vision was assessed using a single-item question in the PROWL-M questionnaire. Participants were asked a question "In general, how satisfied or dissatisfied are you with your present vision". Responses was collected in 6 categories: (1) completely satisfied, (2) very satisfied, (3) somewhat satisfied, (4) somewhat dissatisfied, (5) very dissatisfied, (6) completely dissatisfied. Categories with non-zero data values are reported.

Time frame:
Preoperative (within 120 to 14 days prior to surgery on Day 0), 3 months, 6 months, and 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Experienced Satisfaction With Vision as Measured by PROWL-M Questionnaire
Percentage of participantsWavefront-guided LASIK Monovision Treatment
Completely satisfied: Preoperative11.9
Very satisfied: Preoperative36.5
Somewhat satisfied: Preoperative24.5
Somewhat dissatisfied: Preoperative10.7
Very dissatisfied: Preoperative13.8
Completely dissatisfied: Preoperative2.5
Completely satisfied: 3 months32.5
Very satisfied: 3 months46.5
Somewhat satisfied: 3 months14.6
Somewhat dissatisfied: 3 months3.8
Very dissatisfied: 3 months1.9
Completely dissatisfied: 3 months0.6
Completely satisfied: 6 months40.7
Very satisfied: 6 months42.0
Somewhat satisfied: 6 months12.7
Somewhat dissatisfied: 6 months1.3
Very dissatisfied: 6 months2.7
Completely dissatisfied: 6 months0.7
Completely satisfied: 12 months43.8
Very satisfied: 12 months47.1
Somewhat satisfied: 12 months5.2
Somewhat dissatisfied: 12 months2.6
Very dissatisfied: 12 months1.3
SecondarySubject Satisfaction Score With Surgery as Measured by PROWL-M Questionnaire

A questionnaire derived from the PROWL-M was given to participants after surgery. Satisfaction with LASIK via PROWL-M questionnaire was assessed with 8 items. Responses to individual items were linearly transformed to a 0 to 100 scale where 100 indicates best possible vision and satisfaction, while 0 indicates worst possible vision and satisfaction. Each item score was averaged together to produce a score ranging from 0 to 100. A higher score indicating greater satisfaction.

Time frame:
3 months, 6 months, and 12 months postoperative (operated on Day 0)
Reported as:
Mean · Score on a scale
Subject Satisfaction Score With Surgery as Measured by PROWL-M Questionnaire
Score on a scaleWavefront-guided LASIK Monovision Treatment
3 months83.5 ± 19.5
6 months86.2 ± 18.2
12 months89.7 ± 13.9
SecondaryPercentage of Participants Who Achieved 20/40 Or Better Simultaneous Binocular Uncorrected Visual Acuity (UCVA)

Percentage of participants who achieved 20/40 or better simultaneous binocular UCVA measured using Good-Lite 100 percent (%) proportionally spaced SLOAN letter/ETDRS charts designed for 4.0 meter (m) and the Good-Lite self-illuminated and self-calibrated illumination box were reported.

Time frame:
Preoperative (within 120 to 14 days prior to surgery on Day 0), 3 months, 6 months, and 12 months postoperative (operated on Day 0)
Reported as:
Number · Percentage of participants
Percentage of Participants Who Achieved 20/40 Or Better Simultaneous Binocular Uncorrected Visual Acuity (UCVA)
Percentage of participantsWavefront-guided LASIK Monovision Treatment
Preoperative18.2
3 months93.6
6 months95.3
12 months96.1

Adverse events

Collected over From preoperative (within 120 to 14 days prior to surgery on Day 0) up to 12 months postoperative (operated on Day 0). Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Wavefront-guided LASIK Monovision Treatment0/159 (0%)0/159 (0%)8/159 (5%)
Most frequent other events
Most frequent other events
EventWavefront-guided LASIK Monovision Treatment
Decrease in Best Spectacle Corrected Visual AcuitySurgical and medical procedures8/159

Baseline characteristics

Safety analysis set included all participants who underwent the procedure.

Age, Continuous
Age, Continuous(Years)Wavefront-guided LASIK Monovision Treatment
Mean49.6 ± 4.6
Sex: Female, Male
Sex: Female, Male(Participants)Wavefront-guided LASIK Monovision Treatment
Female112
Male47
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Wavefront-guided LASIK Monovision Treatment
Hispanic or Latino18
Not Hispanic or Latino141
Unknown or Not Reported0
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Wavefront-guided LASIK Monovision Treatment
Asian1
Black7
Caucasian151
08

Study locations

10 sites
  • Maloney Vision Institute
    Los Angeles, California 90024, United States
  • Kraff Eye Institute
    Chicago, Illinois 60602, United States
  • Center for Sight
    Las Vegas, Nevada 89145, United States
  • Coleman Vision
    Albuquerque, New Mexico 87109, United States
  • Vance Thompson Vision
    Sioux Falls, South Dakota 57108, United States
  • Loden Vision Centers
    Goodlettsville, Tennessee 37072, United States
  • Berkeley Eye Institute, P.A.
    Houston, Texas 77027, United States
  • Texas Eye & Laser Center
    Hurst, Texas 76054, United States
  • Utah Eye Center
    Ogden, Utah 84403, United States
  • The Eye Center
    Fairfax, Virginia 22031, United States
09

References and documents

Study documents

  • Study protocol · Oct 15, 2024
  • Statistical analysis plan · Aug 20, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Johnson \& Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04075591
Lead sponsor
AMO Development, LLC
Responsible party
Sponsor
First posted
Aug 30, 2019
Start date
Sep 24, 2019
Primary completion
Jun 25, 2025
Completion
Jun 25, 2025
Results posted
Jul 23, 2026
Last update
Jul 23, 2026

Study contacts

AMO Development, LLC Clinical Trial
study director · AMO Development, LLC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion